Conditions such as impaired post-translational modifications, oxidation, and mutations can lead to SOD1 misfolding and toxic gain of function, initiating protein aggregation events that ultimately lead to ALS-related neurodegeneration [11]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.